Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenues, net	$ 36,289	$ 49,667	$ 111,897	$ 137,909
Cost of revenues	24,037	31,653	72,302	86,919
Gross profit	12,252	18,014	39,595	50,990
Operating expense:
General and administrative	12,089	15,408	39,659	45,366
Research and development	1,022	979	3,178	2,101
Impairment of goodwill	0	13,226	0	13,226
Total operating expense	13,111	29,613	42,837	60,693
Loss from operations	(859)	(11,599)	(3,242)	(9,703)
Other (expense) income:
Interest expense, net	(2,550)	(2,987)	(7,723)	(8,222)
Other income (expense), net	330	(181)	(98)	(231)
Change in fair value of derivative liabilities	6	90	202	50
Total other expense	(2,214)	(3,078)	(7,619)	(8,403)
Loss before income taxes	(3,073)	(14,677)	(10,861)	(18,106)
Income tax benefit (expense)	12	(3,073)	(767)	(3,379)
Net loss	(3,061)	(17,750)	(11,628)	(21,485)
Fixed dividends - Series B Preferred	(317)	(317)	(952)	(952)
Net loss attributable to common stockholders - basic	(3,378)	(18,067)	(12,580)	(22,437)
Net loss attributable to common stockholders - diluted	(3,378)	(18,067)	(12,580)	(22,437)
Comprehensive loss:
Net loss	(3,061)	(17,750)	(11,628)	(21,485)
Other comprehensive loss:
Foreign currency translation adjustment	2,270	(2,854)	1,412	(574)
Total comprehensive loss	$ (791)	$ (20,604)	$ (10,216)	$ (22,059)
Net loss per common share – basic (in dollars per share)	$ (0.34)	$ (1.90)	$ (1.29)	$ (2.39)
Net loss per common share - diluted (in dollars per share)	$ (0.34)	$ (1.90)	$ (1.29)	$ (2.39)
Weighted average number of common shares outstanding – basic (in shares)	9,823	9,484	9,775	9,399
Weighted average number of common shares outstanding – diluted (in shares)	9,823	9,484	9,775	9,399